8-K - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Filer)
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - CHARLES RIVER LABORATORIES INTERNATIONAL filed an 8-K with the SEC on Nov 4 (a notice of a material company event).
Directly affected
- CRL Charles River Laboratories International+10.4% 13d
Named in this report.
Indirectly affected
- XLI Industrial Select Sector SPDR-0.3% 30d
Industrial Select Sector SPDR holds the industrials sector that Charles River Laboratories International belongs to, so it often moves with news about it.
- IQV IQVIA Holdings-2.3% 12d
IQVIA Holdings is a peer of Charles River Laboratories International in commercial physical and biological research; rivals often move on the same news.
- INCY Incyte
Incyte is a peer of Charles River Laboratories International in commercial physical and biological research; rivals often move on the same news.
- MEDP Medpace Holdings+10.0% 12d
Medpace Holdings is a peer of Charles River Laboratories International in commercial physical and biological research; rivals often move on the same news.
- ICLR ICON Public-5.4% 14d
ICON Public is a peer of Charles River Laboratories International in commercial physical and biological research; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| CRL | +6.32% | +2.20% | base | after close | after close | after close | after close |
| XLI | -1.66% | -2.29% | base | after close | after close | after close | after close |
| IQV | +6.28% | +1.87% | base | after close | after close | after close | after close |
| INCY | -0.64% | +2.38% | base | after close | after close | after close | after close |
| MEDP | +4.38% | -1.76% | base | after close | after close | after close | after close |
| ICLR | +5.10% | +3.68% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-04 AccNo: 0001100682-26-000156 Size: 694 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Price since this story was published: Charles River Laboratories International (CRL)
| Company | When | Move | Status |
|---|---|---|---|
| Charles River Laboratories International (CRL) | three days earlier | +2.20% | final price |
| Charles River Laboratories International (CRL) | five days earlier | +6.32% | final price |
| Icon (ICLR) | three days earlier | +3.68% | final price |
| Icon (ICLR) | five days earlier | +5.10% | final price |
| Incyte (INCY) | three days earlier | +2.38% | final price |
| Incyte (INCY) | five days earlier | -0.64% | final price |
| Iqvia Holdings (IQV) | three days earlier | +1.87% | final price |
| Iqvia Holdings (IQV) | five days earlier | +6.28% | final price |
| Medpace Holdings (MEDP) | three days earlier | -1.76% | final price |
| Medpace Holdings (MEDP) | five days earlier | +4.38% | final price |
| Select Sector Spdr Tr (XLI) | three days earlier | -2.29% | final price |
| Select Sector Spdr Tr (XLI) | five days earlier | -1.66% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna sold Charles River Laboratories International (CRL) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 40 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Iqvia Holdings (IQV) (jointly held), worth $15,001 - $50,000 on 14 Sep 2026. That is 51 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Iqvia Holdings (IQV) (held by a dependent child), worth $1,001 - $15,000 on 8 Sep 2026. That is 57 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Iqvia Holdings (IQV) (held by a dependent child), worth $1,001 - $15,000 on 3 Sep 2026. That is 62 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Incyte (INCY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 61 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Icon (ICLR) (jointly held), worth $15,001 - $50,000 on 14 Aug 2026. That is 82 days before publication. Filed 1 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Charles River Laboratories International (CRL)
Companies mentioned with this story
- CRL Charles River Laboratories International
In “8-K - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Filer),” Charles River Laboratories International (CRL) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> CRL
- XLI Select Sector Spdr Tr
In “8-K - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Filer),” Select Sector Spdr Tr (XLI) is linked, with no stored direction, medium confidence. Reason on file: Industrial Select Sector SPDR holds the industrials sector that Charles River Laboratories International belongs to, so it often moves with news about it
- IQV Iqvia Holdings
For “8-K - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Filer),” Iqvia Holdings (IQV) is linked, with no stored direction, medium confidence. Reason on file: IQVIA Holdings is a peer of Charles River Laboratories International in commercial physical and biological research; rivals often move on the same news
- INCY Incyte
In “8-K - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Filer),” Incyte (INCY) is linked, with no stored direction, medium confidence. Reason on file: Incyte is a peer of Charles River Laboratories International in commercial physical and biological research; rivals often move on the same news
- MEDP Medpace Holdings
In “8-K - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Filer),” Medpace Holdings (MEDP) is linked, with no stored direction, medium confidence. Reason on file: Medpace Holdings is a peer of Charles River Laboratories International in commercial physical and biological research; rivals often move on the same news
- ICLR Icon
For “8-K - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Filer),” Icon (ICLR) is linked, with no stored direction, medium confidence. Reason on file: ICON Public is a peer of Charles River Laboratories International in commercial physical and biological research; rivals often move on the same news
Charles River Laboratories International (CRL)
On 4 Nov 2026, “8-K - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Filer)” is the story that connects Charles River Laboratories International (CRL) to this story.
Charles River Laboratories International (CRL) is on the page because SEC 8-K filing -> direct issuer disclosure -> CRL
Select Sector Spdr Tr (XLI) is here too. Its reason reads: Industrial Select Sector SPDR holds the industrials sector that Charles River Laboratories International belongs to, so it often moves with news about it
Price levels for Charles River Laboratories International (CRL)
CRL traded between 275.99 and 312.08 across 11 sessions. The latest close on file is 310.95. IQV traded between 252.56 and 284.29 across 10 sessions. The latest close on file is 262.56. XLI traded between 163.00 and 172.33 across 20 sessions. The latest close on file is 169.73.
How strong the case is around Charles River Laboratories International (CRL)
46 out of 100
“8-K - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (0001100682) (Filer)” scores 46 out of 100. The score uses 1 sources, and 6 linked companies.